Nygaard-Andersen Jette 4
4 · LivaNova PLC · Filed Jun 17, 2026
Research Summary
AI-generated summary of this filing
LivaNova (LIVN) Director Jette Nygaard-Andersen Receives Award
What Happened
- Jette Nygaard-Andersen, a director of LivaNova PLC (LIVN), received a grant of 2,383 restricted stock units (RSUs) on June 15, 2026. The grant was reported as an award (transaction code A) with $0 cash paid at grant; the filing treats these as a derivative award (RSUs), not an open-market purchase or sale.
Key Details
- Transaction date: 2026-06-15; Form 4 filed: 2026-06-17 (timely filing).
- Securities: 2,383 RSUs; Price per share at grant reported as $0.00; total cash consideration $0 (derivative award).
- Shares owned after transaction: not disclosed in the provided filing excerpt.
- Footnotes: F1 — each RSU represents a contingent right to one ordinary share under the 2025 Director Incentive Award Plan and award agreement; F2 — the RSUs vest on June 15, 2027, subject to continued service and plan terms.
- Filing timeliness: filing appears timely (filed within the usual 2-business-day window).
Context
- RSUs are compensation awards that convert into ordinary shares upon vesting; this grant reflects director compensation rather than a market buy or sell. The RSUs vest on June 15, 2027 if service conditions are met, at which point the director would receive shares (or otherwise satisfy tax-withholding per plan terms). This type of award is common for non-employee directors and does not by itself indicate a purchase-driven bullish signal.
Insider Transaction Report
Form 4
LivaNova PLCLIVN
Nygaard-Andersen Jette
Director
Transactions
- Award
Restricted Stock Units
[F1][F2]2026-06-15+2,383→ 2,383 total→ Ordinary Shares (2,383 underlying)
Footnotes (2)
- [F1]Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement.
- [F2]The RSUs, granted under the 2025 Plan, vest on June 15, 2027, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement.
Signature
/s/ Sarah K. Mohr, Attorney-in-Fact|2026-06-17